What is a stock summary page? Click here for an overview.
Business Description
Novaccess Global Inc
NAICS : 541714
SIC : 2836
ISIN : US98385L1026
Description
Novaccess Global Inc is a biopharmaceutical company that is developing novel immunotherapies to treat brain tumor patients in the United States. The company's team of experts is working to strengthen the capability of the human body's defense against cancer.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -27.1 | |||||
| Debt-to-Equity | -0.28 | |||||
| Debt-to-EBITDA | -1.8 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 66.2 | |||||
| 3-Year EPS without NRI Growth Rate | 63.4 | |||||
| 3-Year FCF Growth Rate | 19.7 | |||||
| 3-Year Book Growth Rate | 45.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 83.32 | |||||
| 9-Day RSI | 59.84 | |||||
| 14-Day RSI | 44.42 | |||||
| 3-1 Month Momentum % | -69.23 | |||||
| 6-1 Month Momentum % | -94.74 | |||||
| 12-1 Month Momentum % | -96.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.01 | |||||
| Quick Ratio | 0.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -138.5 | |||||
| Shareholder Yield % | -2805.26 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -1536.53 | |||||
| ROIC % | -20.77 | |||||
| 3-Year ROIIC % | -44.22 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.81 | |||||
| EV-to-EBITDA | -1.81 | |||||
| EV-to-FCF | -6.7 | |||||
| Earnings Yield (Greenblatt) % | -55.25 | |||||
| FCF Yield % | -1657.89 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:XSNX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Novaccess Global Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.11 | ||
| Beta | 2.12 | ||
| 3-Year Sharpe Ratio | -0.4 | ||
| 3-Year Sortino Ratio | -0.57 | ||
| Volatility % | 207.74 | ||
| 14-Day RSI | 44.42 | ||
| 14-Day ATR ($) | 0.000045 | ||
| 20-Day SMA ($) | 0.00025 | ||
| 12-1 Month Momentum % | -96.36 | ||
| 52-Week Range ($) | 0.0002 - 0.019 | ||
| Shares Outstanding (Mil) | 61.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Novaccess Global Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Novaccess Global Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Novaccess Global Inc Frequently Asked Questions
What is Novaccess Global Inc(XSNX)'s stock price today?
The current price of XSNX is $0.00. The 52 week high of XSNX is $0.02 and 52 week low is $0.00.
When is next earnings date of Novaccess Global Inc(XSNX)?
The next earnings date of Novaccess Global Inc(XSNX) is .
Does Novaccess Global Inc(XSNX) pay dividends? If so, how much?
Novaccess Global Inc(XSNX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers